Lista de obras -

5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.

artículo científico publicado en 2013

A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.

artículo científico publicado en 2012

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

artículo científico publicado en 2007

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial

artículo científico publicado en 2015

Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

artículo científico publicado en 2008

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population

scientific article published on 01 July 2018

Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder

artículo científico publicado en 2019

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials

artículo científico publicado en 2015

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

artículo científico publicado en 2016

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

artículo científico publicado en 2005

Delirium associated with paroxetine in an elderly depressive patient: a case report

scientific article published on 01 September 2007

Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA ⬇️

artículo científico publicado el 10 de marzo de 2011

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

scientific article published on 23 July 2020

Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.

artículo científico publicado en 2009

Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.

artículo científico publicado en 2009

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

artículo científico publicado en 2006

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design

scientific article published on 26 April 2019

Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multic

artículo científico publicado en 2014

Estimated cognitive decline in patients with schizophrenia: A multicenter study

artículo científico publicado en 2016

Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder

scientific article published on 01 November 2020

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)

scientific article published on 31 March 2020

Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs

artículo científico publicado en 2015

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

artículo científico publicado en 2015

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis

artículo científico publicado en 2015

Management of chronic depressive patients with residual symptoms.

artículo científico

Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study.

artículo científico publicado en 2015

No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.

artículo científico publicado en 2007

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

artículo científico publicado en 2017

Olfactory reference syndrome treated by blonanserin augmentation ⬇️

artículo científico publicado el 1 de marzo de 2011

Pharmacological Management of Bipolar Disorder: Japanese Expert Consensus

artículo científico publicado en 2020

Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.

artículo científico publicado en 2015

Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.

artículo científico publicado en 2009

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression

artículo científico publicado en 2015

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.

artículo científico

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

artículo científico publicado en 2016

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

artículo científico publicado en 2015

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

article

The serotonin transporter gene and effectiveness of SSRIs.

artículo científico publicado en 2008

Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation.

artículo científico publicado en 2017

Lista de obras de

5-HTTLPR rs25531A > G differentially influence paroxetine and fluvoxamine antidepressant efficacy: a randomized, controlled trial.

A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial

Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population

Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials

Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.

Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.

Delirium associated with paroxetine in an elderly depressive patient: a case report

Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA ⬇️

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis

Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder.

Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.

Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.

Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design

Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multic

Estimated cognitive decline in patients with schizophrenia: A multicenter study

Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)

Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs

HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.

HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis

Management of chronic depressive patients with residual symptoms.

Neuropsychological Evaluation and Cerebral Blood Flow Effects of Apolipoprotein E4 in Alzheimer's Disease Patients after One Year of Treatment: An Exploratory Study.

No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.

Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.

Olfactory reference syndrome treated by blonanserin augmentation ⬇️

Pharmacological Management of Bipolar Disorder: Japanese Expert Consensus

Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4.

Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.

Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.

The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression

The serotonin transporter gene and effectiveness of SSRIs.

Therapeutic Response to Paroxetine in Major Depressive Disorder Predicted by DNA Methylation.